By Leah Douglas and Christy Santhosh April 1 (Reuters) - The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

A new program helps patients safely transition off GLP-1 medications while maintaining results through nutrition, ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

Ready to start a weight loss journey? From GLP‑1 prescriptions to costs, we break down whether Hims customized weight loss ...

Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

Looking for the right weight loss medication but don't know where to turn? This review of Ro Body weight loss GLP-1 could ...

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

Following routine eating patterns and keeping calorie intake steady over time is associated with more weight loss.

In TODAY.com's Expert Tip of the Day, a dietitian shares the dieting red flag she looks for in a weight loss program.

Eating the same meals and keeping calorie intake consistent day after day might be a surprisingly powerful strategy for ...